Evidence map›Paper›PMID 42794529›Full record

ArticleInternational journal of molecular sciences2026

Spindle Cell Tumors with a

L S Hiemcke-Jiwa, P Múdry, E Rullo, B Koopman, A H G Cleven, J M van Gorp, M M van Noesel, R A Schoot, K Polášková, M L Ooft and 8 more

Abstract readCase Reports
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

L S Hiemcke-JiwaPrincess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0002-0332-1673
P MúdryDepartment of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic.ORCID 0000-0003-3434-7937
E RulloPathology Unit, Department of Laboratories, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
B KoopmanDepartment of Pathology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.ORCID 0000-0003-0873-9638
A H G ClevenDepartment of Pathology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
J M van GorpDepartment of Pathology, Location Antonius Hospital, Pathology-DNA, 3435 CM Nieuwegein, The Netherlands.
M M van NoeselPrincess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0003-0503-5838
R A SchootPrincess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
K PoláškováDepartment of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic.
M L OoftDepartment of Pathology, Location Rijnstate Hospital, Pathology-DNA, 6815 AD Arnhem, The Netherlands.
N VecciaPathology Unit, Department of Oncology and Specialist Medicines, Azienda Ospedaliera San Camillo Forlanini, 00152 Rome, Italy.ORCID 0009-0004-0875-2079
R AlaggioPathology Unit, Department of Laboratories, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
S BarresiPathology Unit, Department of Laboratories, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.ORCID 0000-0002-7307-388X
S PatriziOnco-Hematology, Cell Therapy, Gene Therapies and Hemopoietic Transplant, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.ORCID 0000-0003-1898-1516
E MieleOnco-Hematology, Cell Therapy, Gene Therapies and Hemopoietic Transplant, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.ORCID 0000-0002-4747-1032
S van HelvertDepartment of Pathology, Radboud Institute for Medical Innovation, Radboud University Medical Center Nijmegen, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0002-4958-9819
L A KesterPrincess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0002-8259-9971
U FluckePrincess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal neoplasms driven by protein kinases represent an increasing group with a broad clinicopathologic and genetic spectrum. Recently, tumors harboring a

Indexed as

Oncogene Proteins, FusionProto-Oncogene Proteins c-ablSoft Tissue NeoplasmsAdaptor Proteins, Signal TransducingAdolescentAdultAgedChildDNA MethylationFemaleHumansMaleABL1 protein, humanAdaptor Proteins, Signal TransducingGAB1 protein, humanOncogene Proteins, FusionProto-Oncogene Proteins c-ablDNA methylation profilingfusion geneGAB1::ABL1mesenchymal tumorsprotein kinasesoft tissue tumorstyrosine kinase

Identifiers

PMID42794529
PMCPMC13607277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.